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What should WHO be doing about patient safety
and technology?
Oliver T Mytton,1,2 Felix E C Greaves,1,2 Emma A I Stanton,2
Liam J Donaldson1,2
INTRODUCTION
Technology has promised a great deal as a tool for
potentially reducing harm in healthcare, but has
frequently failed to deliver. It can present risks to
patients if used incorrectly. Technology can also
mitigate against risk by reducing error through
improved design of processes or equipment.1e3
Technology is an important thread running
through many areas of patient safety: reporting and
learning, systems thinking, human factors, training
and culture change.3
The opportunities for technology to improve
patient safety are wide-ranging. Commonly
described technological solutions include informa-
tion technology, such as computerised physician
order entry,4 5 as well as design solutions to make
equipment safer to use, such as single-use injection
needles.6 However, such examples fail to capture
the full breadth of opportunities for technology to
improve patient safety.1
At a macro level, regulation is required to ensure
that new technology is introduced safely;7
however, regulation can also act as a barrier to
innovation and lead to delays in implementation.
New technological solutions can increase costs. At
a micro level, workarounds, occurring on the
introduction of technology intended to make care
safer, can make care less safe.8 Healthcare profes-
sionals may resist the implementation of techno-
logical change.9
WHO Patient Safety is looking to develop
a technology programme. As a ﬁrst step to under-
stand the relationship between technology and
patient safety, WHO Patient Safety identiﬁed four
key areas (box 1). Working with Imperial College
London, they established four working groups of
ﬁve to 10 experts for each of these areas. These
groups sought to clarify the role of technology in
improving patient safety, in both the developed and
developing world.
Their reports are published as papers alongside
this paper.2 7 10 11 The group members producing
these papers were invited to a 1-day conference,
held at Imperial College in May 2009 (the WHO
expert meeting), to present their work. In addition,
at this expert meeting, the groups were invited to
present two suggested projects to WHO Patient
Safety, within their area. These proposals are
presented in this paper. This paper draws on this
work (the WHO expert meeting, the papers and the
project proposals) and considers the wider themes
emerging from this work. The paper, together with
the group papers, provides the foundation for the
next stage of the technology programme.
EVALUATION OF PROJECT PROPOSALS
Each of the four working groups proposed two
projects to WHO Patient Safety. The working
groups were advised that their projects would be
considered alongside the priorities of WHO Patient
Safety. Projects might then be undertaken by WHO
Patient Safety as part of the next phase of its
technology programme. The eight project proposals
are shown in table 1.
Delegates from the four working groups attended
the WHO expert meeting, where they presented
their proposals. This expert meeting consisted of
a series of break-out discussions in small groups to
identify the strengths and weakness of each
project. Each delegate at the expert meeting ranked
each project on a ﬁve-point scale, against ﬁve
criteria:
< burden of the problem;
< global nature of the solution and problem;
< potential for the solution to solve the problem;
< value for money;
< ability to use existing technology to solve the
problem.
Scores on the ﬁve criteria were summed, with
each criterion being given equal weight. The
summed scores were averaged. Overall, the two
simulation projects scored the highest. Both of the
simulation projects had immediate face validity and
addressed problems of global importance. The
handover project was the most highly recom-
mended project; delegates at the WHO expert
meeting felt that poor communication at hand-
overs was a global concern. It was proposed that
a structured education tool be developed to
promote uptake. It was suggested that such a tool
could have worldwide impact, as the problem is
universal, and would use low-ﬁdelity simulation,
making it easy to adapt or transfer at lower cost.
CHALLENGES FOR TECHNOLOGY TO IMPROVE
PATIENT SAFETY
Several themes emerged from the group papers,2 7 10 11
the WHO expert meeting and the project proposals.
Those of particular interest are discussed.
Theme 1: information management to understand
errors
We live in an information age. The total volume of
digital data is predicted to increase more than ﬁve
times by 2012.12 The challenge for patient safety is
twofold. First, to manage the rapidly increasing
volume of data so that healthcare professionals
have access to the right information at the right
time to provide safe and timely care. Second, to use,
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and often share, electronically captured information to facilitate
learning and improvements in patient safety. These themes are
strongly echoed in the information technology paper, focussing
on information transaction.2 Such changes take place against
a backdrop of concerns about data protection13 14 and a growing
enthusiasm for some patients to own their medical records.
Much hope is placed in Electronic Medical Records (EMR).3
Brigham and Women’s Hospital in Boston, USA reduced serious
medication errors by 55% following the introduction of
computerised physician order entry systems, and had estimated
savings of US$5e10 million each year.15 The US Department of
Veterans Affairs has doubled vaccination rates, and achieved
substantial improvements in diabetes and acute coronary care,
by changing to electronic records.16 However, the extent to
which EMR have delivered outside a handful of settings remains
unclear. Uptake in both ambulatory care and hospital care in the
USA has been poor.17 Although one-quarter of ofﬁce-based
doctors in the USA reported using EMR systems, less than 10%
of these physicians actually have a ‘complete EMR system.’17
Improving interconnectivity and the quality of data is vital to
optimise their use.2 Improving data quality by identifying
a practical set of quality measures for clinical coding (project
three) reﬂects this theme.
The second challenge identiﬁed is the use of IT to facilitate
efﬁcient reporting and learning. The healthcare community has
been set the challenge of passing the ‘orange wire test’: the
airline industry has the ability to identify and rectify a system-
atic fault in a single orange wire across all aeroplanes within
a period of days.18 Passing the orange wire test depends on an
ability to identify problems rapidly, through data capture,
pooling and analysis, as well as having systems for dissemi-
nating that information to those who can rectify the problem.
Other high-hazard industries also carry out real-time analysis
and reporting. Dow Corning, an international chemical
company, has been widely praised for its safety record. It has
a global incident management system that effectively uses IT to
automatically collate, process and disseminate safety data in real
time.19
Approximately 30 years ago, experts in pharmacovigilance
realised that a new approach was needed to identify drugs
causing adverse events.20 Systems such as ‘i3 Aperio’ in the USA
can be used to routinely scan electronic records for adverse
events associated with the use of new medications or vaccines.
The frequency of adverse events can be compared with similar
patients in the same database who have not used the new
medication or vaccine. Reports are run on a weekly basis to
identify medication risks earlier than otherwise might be the
case. Given the complexity of healthcare and the torrent of data,
automated real-time analysis using information technology
offers the best opportunity for healthcare systems to pass the
orange wire test. Rapid dissemination of information is impor-
tant, reﬂected in project 4, to share best practice.
The importance of communicating information, particularly
at transitions in care, is reﬂected in project 1, simulation to
improve communication at handovers. There are particular
challenges for developing countries. The wide digital divide
among countries shows little sign of narrowing.21 There is
interest in using mobile phones to deliver information and
coordinate action in the developing world;8 22e24 however, the
quality and speed of information transfer by mobile phones are
limited. A more pragmatic approach might be to encourage and
develop broader global access to the internet.
Theme 2: translating information on errors into
safer technology
In 2001, teenager Wayne Jowett died from vincristine poisoning.
Wayne was in remission from leukaemia. Vincristine was
injected intrathecally by mistake by two young doctors, rather
than intravenously. One approach, employed in the UK, to
prevent this happening is to improve awareness and training to
change practice. To date, there have been no reported incidents
of vincristine being administered in the UK by the wrong route
since Wayne Jowett’s tragic death. The National Patient Safety
Agency (NPSA, UK) also reports there have been no near misses.
Further incidents have continued to occur worldwide.25 26 A
second ‘harder solution’ of separate lock and key devices for
intravenous and intrathecal injections creates a physical barrier
to prevent inadvertent administration of intravenous drugs into
the spine. Although various devices have been proposed, none
has yet reached the market. This reﬂects a wider problem that
effective solutions are not readily developed and introduced. The
NPSA recently issued an alert mandating all NHS trusts to use
spinal and epidural injection devices that cannot be connected to
intravenous systems by 2013.27 Such regulation creates a market
for safety devices. Greater use of ﬁnancial incentives, such as
national level purchasing contracts, could stimulate the devel-
opment of safer technologies. More innovative approaches to
collecting information on error, such as video recording of
cardiac arrests, combined with an understanding of ergonomics
and human factors, can produce radically different and safer
designs.28
There was concern expressed at the expert meeting about the
lack of ‘appropriate technology ’ designed speciﬁcally for devel-
oping countries. Appropriate technology is designed with special
consideration to the environmental, ethical, cultural, social,
political and economical aspects of the community for which it
is intended.29 At the WHO expert group meeting, market failure
was suggested as a possible root cause. An alternative approach
to translating information on errors into safer technology is to
give responsibility for innovation to frontline healthcare staff.
This so-called ‘lean’ approach, pioneered by Toyota, has poten-
tial to deliver tailored economical solutions with greater speed.30
Lean thinking has been adopted into healthcare with limited
success.31
Theme 3: dissemination of technology
Inconsistent uptake of medical advances is widely acknowl-
edged. One study estimated that it took 17 years to apply only
Box 1 WHO Patient Safety Technology Programme:
priority-setting exercise
WHO Patient Safety and its stakeholders undertook a scoping
exercise to identify and clarify the role of technology in improving
patient safety in both the developed and developing world. Four
working groups of international experts were created. Group
members had relevant expertise in either technology or patient
safety and reflected the different needs of developed and devel-
oping countries.
The four groups were:
< introducing new technology safely
< making existing technology safer in healthcare
< information technology for patient safety
< training and simulation for patient safety
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10% of knowledge that could be beneﬁcial to patients.32 This
theme is echoed in several of the papers.1 2 7
While other industries have managed to disseminate techno-
logical advances quickly and widely, healthcare has struggled to
achieve the same success. This is partly due to the complexity of
healthcare, with its fragmented structure, and partly due to an
organisational culture that is resistant to change. It seems likely
that different solutions are required in different settings. In
developing countries, poor infrastructure hinders the delivery of
care in the community. Over the past 40 years, US$3.4 trillion
has been spent to address critical diseases in developing coun-
tries;33 however, the impact of this money is limited by the ‘last
mile’ distribution capabilities, leading to inequitable distribution
of resources.33 Technology has a key role to play in communi-
cation, not simply by using new media for communication, but
also by targeting messages to the end user. Organisations such as
Amazon and Google tailor content by observing users’ web-
browsing preferences. A similar approach could be incorporated
into a virtual international forum to promote learning and
sharing of best practice (project 4).
Theme 4: regulation
Any attempt to use technology to improve patient safety will
need to tackle the challenge of regulation. Regulation supports
the safe introduction of technology by ensuring the quality and
safety of new devices;7 however, it can also delay or prevent
safer innovative technology from wider use.7 Concern was
expressed at the WHO expert meeting about how regulation
affects developing countries. Regulatory systems are often
absent or weak in developing countries allowing misguided use
of technology.7 The lack of recognised regulatory bodies for these
countries means that medications and devices intended solely
for developing countries, particularly when deployed by inter-
national organisations, are mandated to pass a regulatory
assessment. This has to occur in a developed country. There is
little incentive for manufacturers to develop devices solely for
developing countries, because the costs associated with regula-
tory assessment and the necessary over engineering are prohib-
itive. This theme was reﬂected in project 8, which proposed
different regulatory standards for developing and developed
countries.
A dual standard could be unethical, as it might promote
differential rights to safe care for people living in different
countries. However, the absence of dual standards might be
acting to prohibit the introduction of appropriate technologies
into developing countries.34 A different regulatory structure, or
at least a different regulatory decision for different environ-
ments, may be seen as ethical, as it could facilitate the intro-
duction of appropriate technology leading to better and safer
healthcare in those settings. Different regulatory decisions
would seem reasonable, given a different background incidence
of disease, tolerance of error and funding possibilities in the
developing world. A similar debate has taken place in research.35
The original standard was that any new innovation had to be
tested against the best standard worldwide. This inhibited
research to show the beneﬁt of new technology or medicines
that conferred a beneﬁt in a particular setting where there might
be other constraints preventing the routine use of the world
‘gold standard’. The modern test is the local gold standard. This
allows research into appropriate and affordable solutions for the
setting.
One theme emerging from the WHO expert meeting was the
need to understand human factors and ergonomics to produce
smarter designs. Devices are often regulated in isolation and
tested under ideal conditions, rather than realistic work condi-
tions. Healthcare practitioners, particularly in developed coun-
tries, are also heavily regulated. However, no body ‘regulates’ the
interaction between technology and healthcare practitioners.
Most medical errors occur not because of individual failure or
‘device failure’ (a device not doing the task it was designed for),
but because of how the design was used in the real world (the
interaction between healthcare practitioner and technology).11
The need for a greater consideration of deviceeuser interaction is
reﬂected in projects 5, 6 and 7. Simulated ward environments
could be used more routinely to develop devices to promote
patient safety and feed directly into regulatory decisions.
Theme 5: using technology to improve safety in developing
countries
There have been signiﬁcant technological advances in healthcare
in the most afﬂuent nations, but concern was expressed at the
expert meeting that their spread to developing countries has
been poor. Funding is a crucial issue. Donor money can establish
a market, as occurred with ﬁxed-dose combination therapy for
tuberculosis36; however, in the present economic climate, the
sustainability of such projects remains uncertain.37
There is a paucity of appropriate technology for developing
countries, reﬂected by the proposal in project 7. Donations of
developed world technology are often unsuitable for local needs
and left unused.7 38 Technology designed for the developed world
is often too expensive and is often poorly designed for the
environment where it will be used. These technologies might be
overly complicated, difﬁcult to maintain or incompatible with
other devices.7 11
Education is important for sustainable development in
developing countries,39 as well as being vital for improving
Table 1 Proposed projects assessed by the delegates
Group Project name Brief description
Introducing new technology safely 1. Design Greater use of appropriate technology in low-resource settings to promote patient safety
Introducing new technology safely 2. Governance Dual standards for technology in high- and low-income countries to facilitate the use of appropriate
technology in developing countries
Making existing technology safer 3. Implementation of technology Establish ways that technology could promote the safer use of medical devices in rural hospitals in
developing countries
Making existing technology safer 4. Integrated technology Assess the cost-effectiveness of using integrated technology to promote safer patient care in
developing countries
Information technology 5. Data quality Improve data quality in electronic records by identifying a practical set of quality measures for
clinical coding
Information technology 6. Forum for sharing best practice Create a virtual international forum to promote learning and sharing of best practice
Simulation 7. Handover simulation Develop a standard handover protocol, using simulation as the tool to teach its use
Simulation 8. Birthing simulator Develop a simulator and program to promote safe childcare delivery
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healthcare. The two simulation projects reﬂect this priority.
Simulation is a hands-on way of learning, which could be well
suited to the developing world.
CONCLUSION: WHO PATIENT SAFETY TECHNOLOGY
PROGRAMME, A LONG-TERM VISION
Technology is, and will continue to be, an important theme for
patient safety. For WHO Patient Safety to take a lead interna-
tionally in improving patient safety, it needs to continue to
incorporate technology within its current thinking and future
work. The technology programme will support WHO Patient
Safety in this role.
The WHO expert meeting, and the four papers presented
here,2 7 10 11 highlighted the breadth and complexity of the
relationship between technology and patient safety. It will be
challenging for WHO Patient Safety alone to develop a tech-
nology programme that has sufﬁcient breadth and depth of skill
to support the needs of its other programmes. A more ﬂexible
approach is required that can tap into a wide global and diverse
skill matrix in academia, industry and policy.
The technology programme, like WHO Patient Safety, needs
to balance implementation, delivering projects with measurable
outcomes, with thought leadership and standard setting. The
latter role might be more inﬂuential, pushing the boundaries and
challenging present thinking. Such a balance can be achieved by
choosing original and innovative projects that demonstrate new
approaches, yet still support other areas of WHO Patient
Safety ’s work.
In the short term, both of the simulation projects, concerning
safe childbirth and promoting safe handovers, are of great
interest. These projects align with other areas of work by WHO
Patient Safety. The technology programme should support
WHO Patient Safety in its aim to promote and make patient
care safer throughout the developed and developing world. This
principle should remain at the heart of future developments for
the technology programme.
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